These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs. Cundy KC; Sue IL; Visor GC; Marshburn J; Nakamura C; Lee WA; Shaw JP J Pharm Sci; 1997 Dec; 86(12):1334-8. PubMed ID: 9423141 [TBL] [Abstract][Full Text] [Related]
6. Bioavailability and reversible metabolism of prednisone and prednisolone in man. Garg V; Jusko WJ Biopharm Drug Dispos; 1994 Mar; 15(2):163-72. PubMed ID: 8011967 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and bioavailability of diltiazem (CRD-401) in dog. Kohno K; Takeuchi Y; Etoh A; Noda K Arzneimittelforschung; 1977 Jul; 27(7):1424-8. PubMed ID: 578467 [TBL] [Abstract][Full Text] [Related]
8. Effect of food on the absorption and pharmacokinetics of prednisolone from enteric-coated tablets. Al-Habet SM; Rogers HJ Eur J Clin Pharmacol; 1989; 37(4):423-6. PubMed ID: 2598978 [TBL] [Abstract][Full Text] [Related]
9. Bioavailability of propranolol in the dog. Tse FL; Sanders TM; Reo JP Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):180-9. PubMed ID: 7224706 [TBL] [Abstract][Full Text] [Related]
10. The effect of food and tablet formulation on plasma prednisolone levels following administration of enteric-coated tablets. Lee DA; Taylor GM; Walker JG; James VH Br J Clin Pharmacol; 1979 May; 7(5):523-8. PubMed ID: 475947 [TBL] [Abstract][Full Text] [Related]
11. Posaconazole pharmacokinetics after administration of an intravenous solution, oral suspension, and delayed-release tablet to dogs. Kendall J; Papich MG Am J Vet Res; 2015 May; 76(5):454-9. PubMed ID: 25909378 [TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration. Täuber U; Haack D; Nieuweboer B; Kloss G; Vecsei P; Wendt H Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):48-55. PubMed ID: 6698661 [TBL] [Abstract][Full Text] [Related]
13. Relative and absolute bioavailability of prednisone and prednisolone after separate oral and intravenous doses. Ferry JJ; Horvath AM; Bekersky I; Heath EC; Ryan CF; Colburn WA J Clin Pharmacol; 1988 Jan; 28(1):81-7. PubMed ID: 3350994 [TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of prednisone and prednisolone. Pickup ME Clin Pharmacokinet; 1979; 4(2):111-28. PubMed ID: 378499 [No Abstract] [Full Text] [Related]
15. Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions. Brewster ME; Anderson WR; Meinsma D; Moreno D; Webb AI; Pablo L; Estes KS; Derendorf H; Bodor N; Sawchuk R; Cheung B; Pop E J Pharm Sci; 1997 Mar; 86(3):335-9. PubMed ID: 9050802 [TBL] [Abstract][Full Text] [Related]
16. Bioavailability of different forms of amoxycillin administered orally to dogs. Küng K; Wanner M Vet Rec; 1994 Dec; 135(23):552-4. PubMed ID: 7886889 [TBL] [Abstract][Full Text] [Related]
17. Absolute and relative bioavailability of lithium dosage forms in the beagle dog. Banarer M; Ritschel WA Arzneimittelforschung; 1982; 32(4):383-8. PubMed ID: 6896645 [TBL] [Abstract][Full Text] [Related]
18. Absolute bioavailability study in the dog with Visacor, a new cardioselective beta blocking drug with intrinsic sympathomimetic activity. McAinsh J; Smith RP; Ferguson RA Eur J Drug Metab Pharmacokinet; 1984; 9(2):129-39. PubMed ID: 6146530 [TBL] [Abstract][Full Text] [Related]